Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001905
Filing Date
2020-03-02
Accepted
2020-03-02 17:10:32
Documents
76
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K albo-20191231x10k.htm 10-K 2717849
2 EX-4.2 albo-20191231ex429cef394.htm EX-4.2 20639
3 EX-21.1 albo-20191231ex211169280.htm EX-21.1 3438
4 EX-23.1 albo-20191231ex231a7826d.htm EX-23.1 5343
5 EX-31.1 albo-20191231ex3119fe54c.htm EX-31.1 11310
6 EX-31.2 albo-20191231ex312352972.htm EX-31.2 10545
7 EX-32.1 albo-20191231ex321c442cc.htm EX-32.1 9393
8 GRAPHIC albo20191231x10k001.jpg GRAPHIC 33791
9 GRAPHIC albo20191231x10k002.jpg GRAPHIC 78055
  Complete submission text file 0001558370-20-001905.txt   7396868

Data Files

Seq Description Document Type Size
10 EX-101.INS albo-20191231.xml EX-101.INS 1202324
11 EX-101.SCH albo-20191231.xsd EX-101.SCH 41822
12 EX-101.CAL albo-20191231_cal.xml EX-101.CAL 59317
13 EX-101.DEF albo-20191231_def.xml EX-101.DEF 137629
14 EX-101.LAB albo-20191231_lab.xml EX-101.LAB 466363
15 EX-101.PRE albo-20191231_pre.xml EX-101.PRE 332809
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33451 | Film No.: 20678109
SIC: 2834 Pharmaceutical Preparations